Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

0.5957 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.5957
Bid (Size) 0.5810 (3)
Ask (Size) 0.6150 (1)
Prev. Close 0.5957
Today's Range 0.5957 - 0.5957
52wk Range 0.5900 - 4.020
Shares Outstanding 29,940,637
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What Analysts Are Saying About DermTech Stock
Via Benzinga
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
From DermTech, Inc.
Via Business Wire

Performance

YTD
-64.11%
-64.11%
1 Month
-9.74%
-9.74%
3 Month
-53.46%
-53.46%
6 Month
-51.17%
-51.17%
1 Year
-84.53%
-84.53%

More News

Read More
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
From DermTech, Inc.
Via Business Wire
Recap: DermTech Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
DermTech Reports Fourth-Quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
From DermTech, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
From DermTech, Inc.
Via Business Wire
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
From DermTech, Inc.
Via Business Wire
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
DERMTECH SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
From Faruqi & Faruqi LLP
Via GlobeNewswire
DMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK
From The Rosen Law Firm, P.A.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)
From The Law Offices of Frank R. Cruz
Via Business Wire
DERMTECH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
DMTK FRIDAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages DermTech, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK
From The Rosen Law Firm PA
Via GlobeNewswire
DERMTECH ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.